By Jennete Ugo Anya
Nigeria’s cancer response system is beginning to shift beyond hospital-based treatment toward a broader support framework addressing the economic and social conditions that often determine whether patients can continue care.
That transition is reflected in the Federal Ministry of Health and Social Welfare (FMOH & SW) National Cancer Control Plan (NCCP) Social Determinants of Health (SDOH) Assistance Programme, which has now received formal endorsement from the Nigerian Cancer Society (NCS).
The programme, introduced through the National Cancer Control Plan Technical Working Group (NCCP TWG), is designed to support cancer patients and survivors facing non-medical challenges that frequently disrupt treatment continuity, including transportation costs, food insecurity and other welfare-related pressures.
The Nigerian Cancer Society (NCS), in a statement signed by its Secretary General, Prof Adamu Danladi Bojude, described the initiative as an important intervention aimed at improving equitable access to cancer care across the country.
The development reflects a growing recognition within Nigeria’s health policy environment that cancer outcomes are shaped not only by medical infrastructure and specialist availability, but also by wider social and economic realities affecting patients and their families.
In many cases, transportation expenses, nutritional challenges and household financial pressures become significant barriers to treatment adherence, particularly for patients requiring repeated visits to specialised oncology centres concentrated in major urban locations.
The SDOH Assistance Programme therefore signals a broader public health approach increasingly focused on the social determinants influencing survival outcomes and continuity of care.
According to the NCS, the framework extends support beyond clinical treatment by incorporating transportation assistance to treatment centres, food and nutritional support, and other non-medical services for patients and caregivers.
The Society stated: “The Nigerian Cancer Society, as the leading national professional body dedicated to cancer control, advocacy, research, prevention, and patient support in Nigeria, has fully endorsed the initiative and continues to play a collaborative role in advancing equitable cancer care across the country.”
The organisation also disclosed that its leadership and members contributed financially to the support fund as part of efforts to strengthen patient assistance mechanisms beyond advocacy and awareness campaigns.
The programme additionally highlights the increasing role of institutional partnerships in Nigeria’s evolving cancer control strategy.
Prof Folakemi Odedina, who leads the FMOH & SW NCCP TWG and also serves on the NCS Board of Trustees representing the diaspora community, was acknowledged for supporting strategic collaboration and partnership development within the sector.
The NCS stressed that non-medical hardship should not prevent patients from accessing treatment.
According to the statement, “No cancer patient should be denied access to care due to transportation costs, food insecurity or other non-medical barriers.”
The first phase of support disbursement is expected later this month, with the programme targeting cancer patients and survivors requiring additional welfare support during treatment.
The initiative also reflects wider pressures facing Nigeria’s healthcare system as rising cancer cases continue to increase demand for long-term treatment support, specialised care infrastructure and patient financing mechanisms.
While policy attention has historically focused heavily on diagnosis and treatment capacity, the programme suggests increasing institutional awareness that treatment success is also linked to broader socioeconomic stability around patients themselves.
The NCS stated that it would continue working with government agencies, healthcare professionals, development partners, advocates and survivor groups to strengthen support systems and improve cancer outcomes nationwide.
As Nigeria’s cancer burden expands, the programme may represent an early attempt to integrate welfare support more directly into national cancer management strategy rather than treating social hardship as separate from healthcare delivery itself.
